Literature DB >> 21395401

A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.

Yuhong Du1, Zaneta Nikolovska-Coleska, Min Qui, Lian Li, Iestyn Lewis, Raymond Dingledine, Jeanne A Stuckey, Krzysztof Krajewski, Peter P Roller, Shaomeng Wang, Haian Fu.   

Abstract

Förster (fluorescence) resonance energy transfer (FRET) and fluorescence polarization (FP) are widely used technologies for monitoring bimolecular interactions and have been extensively used in high-throughput screening (HTS) for probe and drug discovery. Despite their popularity in HTS, it has been recognized that different assay technologies may generate different hit lists for the same biochemical interaction. Due to the high cost of large-scale HTS campaigns, one has to make a critical choice to employee one assay platform for a particular HTS. Here we report the design and development of a dual-readout HTS assay that combines two assay technologies into one system using the Mcl-1 and Noxa BH3 peptide interaction as a model system. In this system, both FP and FRET signals were simultaneously monitored from one reaction, which is termed "Dual-Readout F(2) assay" with F(2) for FP and FRET. This dual-readout technology has been optimized in a 1,536-well ultra-HTS format for the discovery of Mcl-1 protein inhibitors and achieved a robust performance. This F(2) assay was further validated by screening a library of 102,255 compounds. As two assay platforms are utilized for the same target simultaneously, hit information is enriched without increasing the screening cost. This strategy can be generally extended to other FP-based assays and is expected to enrich primary HTS information and enhance the hit quality of HTS campaigns.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395401      PMCID: PMC3148108          DOI: 10.1089/adt.2010.0292

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  35 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  The renaissance of fluorescence resonance energy transfer.

Authors:  P R Selvin
Journal:  Nat Struct Biol       Date:  2000-09

3.  Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.

Authors:  Xiang Wu; J Fraser Glickman; Benjamin R Bowen; Matthew A Sills
Journal:  J Biomol Screen       Date:  2003-08

4.  Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening.

Authors:  Matthew A Sills; Donna Weiss; Quynhchi Pham; Robert Schweitzer; Xiang Wu; Jinzi J Wu
Journal:  J Biomol Screen       Date:  2002-06

5.  Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.

Authors:  Milan Bruncko; Thorsten K Oost; Barbara A Belli; Hong Ding; Mary K Joseph; Aaron Kunzer; Darlene Martineau; William J McClellan; Michael Mitten; Shi-Chung Ng; Paul M Nimmer; Tilman Oltersdorf; Cheol-Min Park; Andrew M Petros; Alexander R Shoemaker; Xiaohong Song; Xilu Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg; Steven W Elmore
Journal:  J Med Chem       Date:  2007-01-26       Impact factor: 7.446

6.  Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.

Authors:  Guoping Wang; Zaneta Nikolovska-Coleska; Chao-Yie Yang; Renxiao Wang; Guozhi Tang; Jie Guo; Sanjeev Shangary; Su Qiu; Wei Gao; Dajun Yang; Jennifer Meagher; Jeanne Stuckey; Krzysztof Krajewski; Sheng Jiang; Peter P Roller; Hatice Ozel Abaan; York Tomita; Shaomeng Wang
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

7.  Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.

Authors:  Guozhi Tang; Chao-Yie Yang; Zaneta Nikolovska-Coleska; Jie Guo; Su Qiu; Renxiao Wang; Wei Gao; Guoping Wang; Jeanne Stuckey; Krzysztof Krajewski; Sheng Jiang; Peter P Roller; Shaomeng Wang
Journal:  J Med Chem       Date:  2007-03-23       Impact factor: 7.446

Review 8.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

9.  Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.

Authors:  S H Kaufmann; J E Karp; P A Svingen; S Krajewski; P J Burke; S D Gore; J C Reed
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

10.  Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.

Authors:  S P Tzung; K M Kim; G Basañez; C D Giedt; J Simon; J Zimmerberg; K Y Zhang; D M Hockenbery
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

View more
  9 in total

1.  A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors.

Authors:  Yuhong Du; Robert W Fu; Bin Lou; Jing Zhao; Min Qui; Fadlo R Khuri; Haian Fu
Journal:  Assay Drug Dev Technol       Date:  2013-08-01       Impact factor: 1.738

2.  Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.

Authors:  Karson J Kump; Lei Miao; Ahmed S A Mady; Nurul H Ansari; Uttar K Shrestha; Yuting Yang; Mohan Pal; Chenzhong Liao; Andrej Perdih; Fardokht A Abulwerdi; Krishnapriya Chinnaswamy; Jennifer L Meagher; Jacob M Carlson; May Khanna; Jeanne A Stuckey; Zaneta Nikolovska-Coleska
Journal:  J Med Chem       Date:  2020-02-14       Impact factor: 7.446

Review 3.  Targeting protein-protein interactions as an anticancer strategy.

Authors:  Andrei A Ivanov; Fadlo R Khuri; Haian Fu
Journal:  Trends Pharmacol Sci       Date:  2013-05-29       Impact factor: 14.819

4.  Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.

Authors:  Ahmed S A Mady; Chenzhong Liao; Naval Bajwa; Karson J Kump; Fardokht A Abulwerdi; Katherine L Lev; Lei Miao; Sierrah M Grigsby; Andrej Perdih; Jeanne A Stuckey; Yuhong Du; Haian Fu; Zaneta Nikolovska-Coleska
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

5.  Development of BODIPY FL VH032 as a High-Affinity and Selective von Hippel-Lindau E3 Ligase Fluorescent Probe and Its Application in a Time-Resolved Fluorescence Resonance Energy-Transfer Assay.

Authors:  Wenwei Lin; Yongtao Li; Lei Yang; Taosheng Chen
Journal:  ACS Omega       Date:  2020-12-29

6.  A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators.

Authors:  Cong Tang; Qiankun Niu; Danielle Cicka; Yuhong Du; Xiulei Mo; Haian Fu
Journal:  STAR Protoc       Date:  2021-09-08

7.  Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors.

Authors:  Jie Zhong; Yuegui Guo; Shaoyong Lu; Kun Song; Ying Wang; Li Feng; Zhen Zheng; Qiufen Zhang; Jiacheng Wei; Peng Sang; Yan Shi; Jianfeng Cai; Guoqiang Chen; Chen-Ying Liu; Xiuyan Yang; Jian Zhang
Journal:  Nat Commun       Date:  2022-08-24       Impact factor: 17.694

8.  Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).

Authors:  Andrew M Beekman; Maria A O'Connell; Lesley A Howell
Journal:  ChemMedChem       Date:  2015-11-30       Impact factor: 3.466

9.  Peptide-Directed Binding for the Discovery of Modulators of α-Helix-Mediated Protein-Protein Interactions: Proof-of-Concept Studies with the Apoptosis Regulator Mcl-1.

Authors:  Andrew Michael Beekman; Maria Anne O'Connell; Lesley Ann Howell
Journal:  Angew Chem Int Ed Engl       Date:  2017-07-25       Impact factor: 15.336

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.